Dapagliflozin Devatis 5 mg, Filmtabletten - 98 Swissmedic Key 69746002 Registration Holder Devatis AG Name Dapagliflozin Devatis 5 mg, Filmtabletten Date of registration 16.01.2025 Introduction of Sequence 16.01.2025 ATC-Classification Dapagliflozin (A10BK01) Revision date WHO WHO-DDD Valid until 15.01.2030 Index Therapeuticus (BSV) Show package size 98 Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680697460023 Medication Code Synthetika Pharmacode Disponibility
Composition dapagliflozinum 5 mg, cellulosum microcristallinum, lactosum 28.03 mg, carmellosum natricum conexum, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 0.53 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Dapagliflozinum 5 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Lactosum 28.03 mg Macrogol 4000 Natrii Stearylis Fumaras Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 07.02.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
